MARKET

LGND

LGND

Ligand Pharma
NASDAQ
284.47
-4.78
-1.65%
After Hours: 284.47 0 0.00% 19:30 09/11 EDT
OPEN
291.48
PREV CLOSE
289.25
HIGH
294.00
LOW
283.77
VOLUME
261.17K
TURNOVER
--
52 WEEK HIGH
326.63
52 WEEK LOW
161.82
MARKET CAP
5.67B
P/E (TTM)
30.26
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LGND last week (0831-0904)?
Weekly Report · 5d ago
If You Invested $100 In Ligand Pharmaceuticals Stock 5 Years Ago, You Would Have This Much Today
Benzinga · 09/02 21:00
Weekly Report: what happened at LGND last week (0824-0828)?
Weekly Report · 08/31 09:48
Ligand to Participate in September Investor Conferences
Barchart · 08/26 06:00
Weekly Report: what happened at LGND last week (0817-0821)?
Weekly Report · 08/24 09:49
$100 Invested In Ligand Pharmaceuticals 10 Years Ago Would Be Worth This Much Today
Benzinga · 08/21 14:45
Ligand Pharmaceuticals Earnings Call Signals Royalty-Driven Surge
TipRanks · 08/18 00:27
Ligand price target raised to $390 from $387 at Citi
TipRanks · 08/17 10:07
More
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company. It operates as a royalty aggregator, partnering with biopharmaceutical companies to finance and advance late-stage clinical development programs. It owns and manages portfolios of biopharmaceutical royalties, with economic interests in more than 200 development and commercial-stage assets. It funds high-value programs in exchange for long-term economic interests. It also licenses its proprietary technologies, Captisol and NITRICIL, to support drug development and formulation across its global partner network. Its commercial products include Roche's VABYSMO (faricimab-svoa), Servier's OJEMDA (tovorafenib), and Zevra Therapeutics' MIPLYFFA (arimoclomol). Additionally, it includes 14 late-stage development programs, featuring Takeda’s mezagitamab and certain assets from Takeda’s externalized asset portfolio, such as osavampator, volixibat, and OHB-607, along with more than 100 assets in various stages of development.

Webull offers Ligand Pharmaceuticals Inc stock information, including NASDAQ: LGND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGND stock methods without spending real money on the virtual paper trading platform.